<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00787176</url>
  </required_header>
  <id_info>
    <org_study_id>0524-034</org_study_id>
    <nct_id>NCT00787176</nct_id>
  </id_info>
  <brief_title>The Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes</brief_title>
  <official_title>The Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fetal heart rate patterns are an important parameter in the diagnosis of non-reassuring fetal&#xD;
      status. Combined-spinal epidural analgesia is a method of initiating labor analgesia used by&#xD;
      approximately 90% of the parturients at Prentice Women's Hospital. Optimizing the variables&#xD;
      which could affect fetal heart rate patterns at the time of initiation of analgesia, such as&#xD;
      fluid administration and oxytocin management, could help us provide better care for our&#xD;
      patients and their fetuses.&#xD;
&#xD;
      Hypotheses: The combination of fluid administration and lower doses of oxytocin&#xD;
      administration will have fewer adverse fetal heart rate changes in the first 60 minutes&#xD;
      following initiation of labor analgesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After obtaining informed, written consent, candidates were randomized to one of four groups&#xD;
      at the time of request for labor analgesia. All subjects received a maintenance infusion of&#xD;
      Lactated Ringers(LR). For candidates in Groups A or B, an intravenous bolus of 1000 mL of LR&#xD;
      was initiated. Candidates in Groups C and D did not receive any additional fluid. If&#xD;
      randomized to group A or C, the oxytocin management was continued as per the normal active&#xD;
      management of labor protocal (AMOL). If randomized to groups B or D, the dose of oxytocin&#xD;
      that was being administered was halved and not increased until 60 minutes after the&#xD;
      initiation of epidural analgesia. Fetal heart rate monitoring and frequency of uterine&#xD;
      contractions were recorded by external tocodynamometry.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study concluded prematurely prior to meeting intended goal recruitment.&#xD;
  </why_stopped>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of non-reassuring fetal heart rate tracings during the first 60 minutes after the placement of epidural analgesia</measure>
    <time_frame>Request for labor analgesia up to the first 60 minutes after the placement of epidural</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">252</enrollment>
  <condition>Pregnancy</condition>
  <condition>Labor Pain</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>An intravenous bolus of 1000 mL Lactated Ringers initiated when the patient was positioned for epidural placement. Oxytocin management continued as per protocol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>An intravenous bolus of 1000 mL Lactated Ringers. The dose of oxytocin being administered at time of epidural placement was halved and not increased for 60 minutes until after placement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The maintenance infusion of 125 mL/hr of Lactated Ringers was given with no additional fluid bolus. Oxytocin management continued per protocol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The maintenance infusion of 125 mL/hr of Lactated Ringers was given with no additional fluid bolus. The dose of oxytocin being administered at time of epidural placement was halved and not increased for 60 minutes until after placement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lactated Ringers bolus of 1000 ml</intervention_name>
    <description>Lactated Ringers bolus of 1000 ml initiated at patient positioning for epidural placement</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No additional fluid</intervention_name>
    <description>Regular maintenance infusion of Lactated Ringers @ 125 ml/hr; no additional fluids</description>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_label>Group D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Routine oxytocin</intervention_name>
    <description>per regular oxytocin protocols</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Half-dose oxytocin</intervention_name>
    <description>The dose of oxytocin currently being administered will be halved and not increased until after 60 minutes after initiation of labor analgesia</description>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group D</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-60&#xD;
&#xD;
          -  Healthy nulliparous or multiparous women&#xD;
&#xD;
          -  Term (&gt;36 week gestation)&#xD;
&#xD;
          -  Singleton pregnancy&#xD;
&#xD;
          -  Spontaneous labor or with spontaneous rupture of membranes&#xD;
&#xD;
          -  Receive oxytocin&#xD;
&#xD;
          -  Request neuraxial analgesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Under 18 years of age&#xD;
&#xD;
          -  Presence of any systemic disease (e.g., diabetes mellitus, hypertension, preeclampsia)&#xD;
&#xD;
          -  Use of chronic analgesic medications&#xD;
&#xD;
          -  Prior administration of systemic opioid labor analgesia&#xD;
&#xD;
          -  Non-vertex presentation&#xD;
&#xD;
          -  Induction of labor&#xD;
&#xD;
          -  Contraindication to neuraxial analgesia.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cynthia A Wong, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Prentice Women's Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mardirosoff C, Dumont L, Boulvain M, Tramèr MR. Fetal bradycardia due to intrathecal opioids for labour analgesia: a systematic review. BJOG. 2002 Mar;109(3):274-81. Review.</citation>
    <PMID>11950182</PMID>
  </reference>
  <reference>
    <citation>Clarke VT, Smiley RM, Finster M. Uterine hyperactivity after intrathecal injection of fentanyl for analgesia during labor: a cause of fetal bradycardia? Anesthesiology. 1994 Oct;81(4):1083.</citation>
    <PMID>7943823</PMID>
  </reference>
  <reference>
    <citation>López-Zeno JA, Peaceman AM, Adashek JA, Socol ML. A controlled trial of a program for the active management of labor. N Engl J Med. 1992 Feb 13;326(7):450-4.</citation>
    <PMID>1732771</PMID>
  </reference>
  <verification_date>October 2015</verification_date>
  <study_first_submitted>November 6, 2008</study_first_submitted>
  <study_first_submitted_qc>November 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2008</study_first_posted>
  <last_update_submitted>October 29, 2015</last_update_submitted>
  <last_update_submitted_qc>October 29, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Cynthia Wong</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Oxytocin</keyword>
  <keyword>Labor, Obstetric</keyword>
  <keyword>Non-reassuring fetal heart rate</keyword>
  <keyword>epidural</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>September 25, 2017</submitted>
    <returned>October 23, 2017</returned>
    <submitted>June 18, 2020</submitted>
    <returned>July 1, 2020</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

